Haw Par Corp. Ltd. (HAWPF)
10.80
0.00 (0.00%)
USD |
OTCM |
Oct 05, 16:00
Haw Par Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2019 | 13.43M |
| September 30, 2019 | -1.363M |
| June 30, 2019 | -0.5654M |
| March 31, 2019 | -0.1616M |
| December 31, 2018 | -1.428M |
| September 30, 2018 | -1.579M |
| June 30, 2018 | -1.058M |
| March 31, 2018 | 49.99M |
| December 31, 2017 | 21.05M |
| September 30, 2017 | -2.933M |
| June 30, 2017 | -2.031M |
| March 31, 2017 | -0.6302M |
| December 31, 2016 | -0.6688M |
| September 30, 2016 | -15.01M |
| June 30, 2016 | -0.0631M |
| March 31, 2016 | 8.107M |
| December 31, 2015 | -0.6135M |
| September 30, 2015 | 4.67M |
| June 30, 2015 | 11.94M |
| March 31, 2015 | -0.2586M |
| December 31, 2014 | -11.56M |
| September 30, 2014 | 6.702M |
| June 30, 2014 | -0.6334M |
| March 31, 2014 | -27.46M |
| December 31, 2013 | -0.3878M |
| Date | Value |
|---|---|
| September 30, 2013 | -0.536M |
| June 30, 2013 | -0.5865M |
| March 31, 2013 | -1.332M |
| December 31, 2012 | -3.194M |
| September 30, 2012 | -0.0287M |
| June 30, 2012 | 7.829M |
| March 31, 2012 | -5.811M |
| December 31, 2011 | -15.27M |
| September 30, 2011 | -23.76M |
| June 30, 2011 | -1.298M |
| March 31, 2011 | -1.944M |
| December 31, 2010 | 2.150M |
| September 30, 2010 | -0.0769M |
| June 30, 2010 | 16.01M |
| March 31, 2010 | -0.9211M |
| December 31, 2009 | -3.145M |
| September 30, 2009 | -3.054M |
| June 30, 2009 | -8.161M |
| March 31, 2009 | -2.728M |
| December 31, 2008 | -3.672M |
| September 30, 2008 | -17.21M |
| June 30, 2008 | -0.9576M |
| March 31, 2008 | 4.949M |
| December 31, 2007 | -12.68M |
| September 30, 2007 | -0.3735M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| AstraZeneca PLC | -1.856B |
| ANI Pharmaceuticals, Inc. | -3.054M |
| Corcept Therapeutics, Inc. | -29.24M |
| Veru, Inc. | 1.802M |
| Avadel Pharmaceuticals Plc | -8.788M |
Cash from Investing (Quarterly) Related Metrics
| Free Cash Flow | 177.97M |
| Free Cash Flow Yield | 7.44% |